Search results for: 'biologicals industry'

This research service considers the biologics market in Brazil. It covers the markets move toward greater regulation and outlines the impact of specific patent expirations. An analysis of monoclonal antibodies, blood factors, insulin, filgrastim, interferon, growth hormones, and erythropoietin is provided. This service also highlights key marke...

Brazil’s telemedicine market is likely to increase from $495.3 million in 2015 to $743.8 million in 2017 whereas the mHealth market revenue will grow from $446.8 million to $1.43 billion over the same period. Telemedicine is strongly focused on teleradiology in Brazil, which represents over 98% of the market segment revenue. Other telemedicine appl...

This research service analyzes the Argentinean, Brazilian, and Mexican picture archiving communication system (PACS) market regarding its revenue, installed base, market share, and competitive scenario. Although the region is still far behind North America and Europe in terms of penetration of the solutionswhere the installed base reaches more tha...

This research service presents an overview and analysis of the Latin American Contract Research Organization (CRO) market with a focus on Argentina, Brazil, and Mexico. It provides country revenue by phase, therapeutic type, and region. The study discusses key challenges and emerging market trends, while providing detailed information on support se...

26 Dec 2017  |  Latin America  |  Market Research

PACS and Integrated PACS Market Assessment in Brazil, Forecast to 2021

SaaS Models, Integrated Analytics Tools on the Rise, Further Advancing Market Maturity

Infographics

×

Key Issues Addressed

Brazil currently spends over $80 million on PACS and integrated PACS systems, considering only the software involved. The overall penetration is increasing, although adoption varies significantly among geographical regions and by the size of institutions. While large-size hospitals and diagnostic centers are almost fully penetrated and are almost e...